Psychedelics poised to revolutionize treatment for mental disorders
Recent studies suggest that psychedelics may aid in the treatment of mental and neurological disorders. It appears that these substances enhance the brain's neuroplasticity and positively impact the treatment of anxiety and post-traumatic stress disorder. Will we be able to purchase LSD or psilocybin at the pharmacy in the future?
Psychedelics can have therapeutic effects, but only under certain conditions. In recent years, an increasing number of studies indicate that these substances can support the treatment of depression, PTSD, anxiety, and addictions, especially when combined with psychotherapy.
A new approach to therapy
Researchers from the University of Michigan have discovered that a single administration of psychedelics significantly improves cognitive functions of the brain. The results of these studies may greatly impact psychiatry and modern therapeutic methods, offering support to patients with various conditions, including those who have not been helped by traditional medications.
The study's findings could revolutionize psychiatry by introducing new therapeutic methods for patients unresponsive to conventional pharmacology. Research on psychedelics began as early as the 1950s, generating significant interest among scientists. Substances such as LSD and psilocybin were analyzed for their potential application in treating depression, alcoholism, and anxiety, as well as for their support in psychotherapy. Many early studies yielded promising results, with patients reporting substantial changes in self-perception and a reduction in psychological symptoms. Despite these positive outcomes, the substances began to be used outside of scientific control, leading to widespread use of psychoactive substances and resulting in strong political and social opposition, ultimately culminating in their prohibition.
The journal "Psychedelics" published studies demonstrating that mice given a single dose of 25CN-NBOH performed better in learning reversal tasks compared to the control group. Notably, these positive effects were visible even two to three weeks after administration.
Long-term benefits
Cellular analyses confirm that psychedelics alter the structure of the prefrontal cortex, improving brain function. Researchers emphasize that the benefits may persist long after the drug's direct effects have worn off.
This research provides evidence of the therapeutic effects of psychedelics and may be a step forward in treating diseases resistant to current therapies. Treatments involving these substances can produce effects lasting several months.
